Buffalo General joins New York City-based Mount Sinai Health System and Pittsburgh-based UPMC as health systems participating in the trial, according to a March 20 Synchron news release.
The Command Trial will primarily focus on safety while also beginning to assess the efficacy of the Synchron Switch, a brain-computer interface device designed to allow people with limited or no mobility to control technology using their thoughts.
The FDA granted breakthrough device designation to Synchron in August 2020.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
